COVID: New Antibody Treatment Could Offer Up To 18 Months’ Protection Against Severe Disease – IFLScience

A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial the final stage of testing before a drug is authorised that suggest its new COVID treatment, AZD7442, is effective…

Click here to view the original article.